scispace - formally typeset
A

Andrew W. Nicholls

Researcher at GlaxoSmithKline

Publications -  59
Citations -  9576

Andrew W. Nicholls is an academic researcher from GlaxoSmithKline. The author has contributed to research in topics: Proton NMR & Metabolomics. The author has an hindex of 28, co-authored 59 publications receiving 7994 citations. Previous affiliations of Andrew W. Nicholls include University of London & The Hertz Corporation.

Papers
More filters
Journal ArticleDOI

Integrated Metabonomic Analysis of the Multiorgan Effects of Hydrazine Toxicity in the Rat

TL;DR: Alanine levels were observed in all tissues indicative of a general inhibition of alanine transaminase activity and NMR spectral profiles of treated rats appeared similar to those of matched controls for all tissue types indicative of recovery from toxic insult.
Journal ArticleDOI

The importance of experimental design and QC samples in large-scale and MS-driven untargeted metabolomic studies of humans.

TL;DR: The importance of experimental design, the separation of the biological study into multiple analytical experiments and the incorporation of QC samples to provide the ability to perform signal correction in order to reduce analytical variation and to quantitatively determine analytical precision is described.
Journal ArticleDOI

Chemometric models for toxicity classification based on NMR spectra of biofluids

TL;DR: Chemometric analysis of the control urine spectra indicated that HW rat urine contained relatively higher concentrations of lactate, acetate, and taurine and lower concentrations of hippurate than SD rat urine, which will enable on-line toxicological assessment of biofluids and will provide a tool for probing the mechanistic basis of organ toxicity.